Page last updated: 2024-08-21

benzoxazoles and Proteinuria

benzoxazoles has been researched along with Proteinuria in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Chihara, A; Nakamura, T; Node, K; Sato, E; Tanaka, A1
Dispenzieri, A; Gertz, MA1
Alves, C; Beirão, I; Cardoso, M; Coelho, T; Lobato, L; Rocha, A; Silva, A; Teles, P1
Hineno, A; Ichikawa, T; Ikeda, SI; Makino, M1

Reviews

1 review(s) available for benzoxazoles and Proteinuria

ArticleYear
Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review.
    JAMA, 2020, 07-07, Volume: 324, Issue:1

    Topics: Algorithms; Benzoxazoles; Dexamethasone; Diagnosis, Differential; Gene Silencing; Heart Failure; Humans; Immunoglobulin Light-chain Amyloidosis; Liver Transplantation; Melphalan; Prognosis; Proteinuria; Stem Cell Transplantation

2020

Trials

1 trial(s) available for benzoxazoles and Proteinuria

ArticleYear
Transthyretin (ATTR) amyloidosis nephropathy: lessons from a TTR stabilizer molecule.
    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2017, Volume: 24, Issue:sup1

    Topics: Adult; Amyloid; Amyloid Neuropathies, Familial; Benzoxazoles; Biomarkers; Creatinine; Cystatin C; Drug Administration Schedule; Female; Gene Expression; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Mutation; Nephritis; Prealbumin; Prospective Studies; Proteinuria

2017

Other Studies

2 other study(ies) available for benzoxazoles and Proteinuria

ArticleYear
Effect of pemafibrate, a novel selective peroxisome proliferator-activated receptor-alpha modulator (SPPARMα), on urinary protein excretion in IgA nephropathy with hypertriglyceridemia.
    CEN case reports, 2020, Volume: 9, Issue:2

    Topics: Adult; Atherosclerosis; Benzoxazoles; Butyrates; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Hypertriglyceridemia; Male; Middle Aged; PPAR alpha; Proteins; Proteinuria; Renal Insufficiency; Treatment Outcome

2020
Tafamidis dramatically improved severe proteinuria in a patient with TTR V30M hereditary ATTR amyloidosis.
    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis, 2019, Volume: 26, Issue:2

    Topics: Aged; Amyloid Neuropathies, Familial; Benzoxazoles; Humans; Male; Middle Aged; Mutation, Missense; Prealbumin; Proteinuria; Treatment Outcome

2019